We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.68B
AUM Growth
-$181M
Cap. Flow
-$34.8M
Cap. Flow %
-0.74%
Top 10 Hldgs %
8.18%
Holding
777
New
55
Increased
288
Reduced
331
Closed
83

Sector Composition

Rank Sector Weight
1 Industrials 19.39%
2 Financials 18.62%
3 Healthcare 16.37%
4 Technology 13.36%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUT icon
351
Outfront Media
OUT
$5.29B
$4.24M 0.09%
+301,043
New +$4.41M
CBT icon
352
Cabot Corp
CBT
$4.46B
$4.23M 0.09%
46,013
-22,990
-33% -$2.23M
CTO
353
CTO Realty Growth
CTO
$805M
$4.22M 0.09%
241,774
+253
+0.1% +$4.38K
GILD icon
354
Gilead Sciences
GILD
$165B
$4.21M 0.09%
61,387
+21,167
+53% +$1.41M
ONTO icon
355
Onto Innovation
ONTO
$14.3B
$4.17M 0.09%
19,013
-1,392
-7% -$288K
CUZ icon
356
Cousins Properties
CUZ
$4.83B
$4.16M 0.09%
179,797
-67,171
-27% -$1.55M
CDMO
357
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4.15M 0.09%
581,237
-15,852
-3% -$121K
CDP icon
358
COPT Defense Properties
CDP
$4.14B
$4.13M 0.09%
165,154
+24,523
+17% +$589K
AAOI icon
359
Applied Optoelectronics
AAOI
$11.2B
$4.12M 0.09%
497,305
+34,092
+7% +$375K
PEP icon
360
PepsiCo
PEP
$188B
$4.09M 0.09%
24,810
IWS icon
361
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$4.07M 0.09%
33,711
+24,449
+264% +$2.97M
PRGS icon
362
Progress Software
PRGS
$1.78B
$4.06M 0.09%
74,736
+11,314
+18% +$574K
AX icon
363
Axos Financial
AX
$5.63B
$3.98M 0.09%
69,574
-5,055
-7% -$275K
OIS icon
364
Oil States International
OIS
$534M
$3.93M 0.08%
884,305
+366,599
+71% +$1.76M
NBIX icon
365
Neurocrine Biosciences
NBIX
$16.8B
$3.92M 0.08%
28,480
-4,756
-14% -$652K
ABT icon
366
Abbott
ABT
$188B
$3.91M 0.08%
37,662
+15,615
+71% +$1.66M
NKE icon
367
Nike
NKE
$62.5B
$3.91M 0.08%
51,872
-6,160
-11% -$572K
SKWD icon
368
Skyward Specialty Insurance
SKWD
$2.51B
$3.91M 0.08%
107,975
+9,534
+10% +$346K
IIIN icon
369
Insteel Industries
IIIN
$626M
$3.9M 0.08%
126,049
-108,010
-46% -$3.54M
NRIM icon
370
Northrim BanCorp
NRIM
$588M
$3.9M 0.08%
270,536
+54,504
+25% +$702K
COGT icon
371
Cogent Biosciences
COGT
$7.1B
$3.88M 0.08%
459,938
-245,693
-35% -$1.86M
GDDY icon
372
GoDaddy
GDDY
$11.6B
$3.86M 0.08%
27,642
-2,952
-10% -$390K
ICUI icon
373
ICU Medical
ICUI
$4.56B
$3.84M 0.08%
32,313
+9,554
+42% +$1.01M
THRM icon
374
Gentherm
THRM
$1.27B
$3.76M 0.08%
76,181
+11,401
+18% +$589K
SCHL icon
375
Scholastic
SCHL
$807M
$3.76M 0.08%
105,921
+59,635
+129% +$2.13M

Similar funds

Kennedy Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Kennedy Capital Management held 777 positions worth $4.68B, down 3.7% from $4.86B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Kennedy Capital Management's Q2 2024 filing shows 55 new, 288 increased, 331 reduced and 83 closed positions. Its largest new stake was Selective Insurance: 141,753 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $14.7M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kennedy Capital Management's largest Q2 2024 buy was Selective Insurance: 141,753 shares worth $13.3M.
  • Kennedy Capital Management added most to Hexcel in Q2 2024, an estimated $19.5M increase.
  • Kennedy Capital Management's biggest Q2 2024 reduction was Blue Bird Corp, cutting an estimated $13.3M.
  • Kennedy Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.7M.
  • Kennedy Capital Management's ten largest holdings make up 8.2% of its $4.68B portfolio in Q2 2024.
  • Kennedy Capital Management opened 55 new positions and closed 83 in Q2 2024.
  • Kennedy Capital Management's portfolio value fell 3.7% quarter-over-quarter to $4.68B.

Based on Kennedy Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.